The Development of Novel Vorapaxar Analogues as Topical Protease Activated Receptor-1 Antagonists for the Treatment of Idiopathic Pulmonary Fibrosis

EF Knight - 2016 - discovery.ucl.ac.uk
The overall aim of this project was to design and synthesise novel Protease Activated
Receptor-1 (PAR-1) inhibitors in order to develop a novel treatment for Idiopathic Pulmonary …
被引用次数：4 相关文章